- Home
- WTBA vs VNDA Comparison
WTBA vs VNDA Comparison
Compare WTBA & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | VNDA |
|---|---|---|
| Founded | 1893 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 342.0M | 398.9M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | WTBA | VNDA |
|---|---|---|
| Price | $22.54 | $7.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $23.50 | $14.00 |
| AVG Volume (30 Days) | 37.0K | ★ 1.3M |
| Earning Date | 01-29-2026 | 02-12-2026 |
| Dividend Yield | ★ 4.40% | N/A |
| EPS Growth | ★ 49.53 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | $91,783,000.00 | ★ $212,074,000.00 |
| Revenue This Year | $25.05 | $12.01 |
| Revenue Next Year | $10.87 | $21.57 |
| P/E Ratio | $11.95 | ★ N/A |
| Revenue Growth | ★ 19.66 | 11.12 |
| 52 Week Low | $17.31 | $3.81 |
| 52 Week High | $24.27 | $7.20 |
Technical Indicators
Market Signals| Indicator | WTBA | VNDA |
|---|---|---|
| Relative Strength Index (RSI) | 48.55 | 67.61 |
| Support Level | $23.47 | $6.75 |
| Resistance Level | $24.27 | $7.20 |
| Average True Range (ATR) | 0.54 | 0.47 |
| MACD | -0.14 | 0.04 |
| Stochastic Oscillator | 21.82 | 87.77 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.